Gene expression profiling of cardiovascular disease models

Current Opinion in Biotechnology

Volumn 11, Issue 6, 2000, Pages 598-601

  Shiffman, Dov ^a   Porter, J Gordon ^b  

^a CV THERAPEUTICS INC   (United States)

^b Department of Life Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; ISOPRENALINE; OXIDIZED LOW DENSITY LIPOPROTEIN; RETINOID X RECEPTOR;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CELL INTERACTION; DISEASE COURSE; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETIC DISORDER; HEART HYPERTROPHY; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0033635111     PISSN: 09581669     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0958-1669(00)00150-6     Document Type: Review

References (27)

1. The intima: Soil for atherosclerosis and restenosis
2. The pathogenesis of atherosclerosis: A perspective for the 1990s
3. Molecular and cellular biology of cardiac hypertrophy and failure
4. Gene expression analysis by transcript profiling coupled to gene database query
5. Expression of the α1 and α2 chains of type IV collagen in the infarct zone of rat myocardial infarction
6. Assessment of cardiac function and gene expression at an early phase after myocardial infarction
7. Collagen remodeling after myocardial infarction in the rat heart
8. Alterations in cardiac gene expression during the transition from stable hypertrophy to heart failure. Marked upregulation of genes encoding extracellular matrix components
9. Application of cDNA microarrays in determining molecular phenotype in cardiac growth, development, and response to injury
10. Altered patterns of gene expression in response to myocardial infarction
11. Expression profiling reveals distinct sets of genes altered during induction and regression of cardiac hypertrophy
12. SPARC (osteonectin/BM-40)
13. Transcriptional profile of mechanically induced genes in human vascular smooth muscle cells
14. Factor VIIa and thrombin induce the expression of Cyr61 and connective tissue growth factor, extracellular matrix signaling proteins that could act as possible downstream mediators in factor VIIa x tissue factor-induced signal transduction
15. Large scale gene expression analysis of cholesterol loaded macrophages
16. Oxidized LDL modulates activation of NFkappaB in mononuclear phagocytes by altering the degradation if IkappaBs
17. 4-Hydroxynonenal prevents NF-kappaB activation and tumor necrosis factor expression by inhibiting IkappaB phosphorylation and subsequent proteolysis
18. Interleukin 8 is induced by cholesterol loading of macrophages and expressed by macrophage foam cells in human atheroma
19. Expression of the peroxisome proliferator-activated receptor gamma (PPARgamma) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein
20. Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats
21. CD36 is a receptor for oxidized low density lipoprotein
22. Absence of Cd36 mutation in the original spontaneously hypertensive rats with insulin resistance
23. Genetics of CD36 and the clustering of multiple cardiovascular risk factors in spontaneous hypertension
24. The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway
25. Assignment of Tangier disease to chromosome 9q31 by a graphical linkage exclusion strategy
26. A spatial approach to transcriptional profiling: Mechanotransduction and the focal origin of atherosclerosis
27. New target regions for human hypertension via comparative genomics